vs
Side-by-side financial comparison of First Bancorp, Inc (FNLC) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $25.8M, roughly 1.5× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs 35.9%, a 3.5% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $34.6M). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs -15.0%).
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
FNLC vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.8M | $39.6M |
| Net Profit | $10.2M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 48.1% | 32.5% |
| Net Margin | 39.4% | 35.9% |
| Revenue YoY | 17.5% | -10.9% |
| Net Profit YoY | 39.7% | 117.2% |
| EPS (diluted) | $0.91 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.8M | $39.6M | ||
| Q3 25 | $24.5M | $43.4M | ||
| Q2 25 | $22.5M | $43.4M | ||
| Q1 25 | $21.8M | $47.3M | ||
| Q4 24 | $22.0M | $44.4M | ||
| Q3 24 | $20.5M | $53.1M | ||
| Q2 24 | $19.2M | $53.1M | ||
| Q1 24 | $18.5M | $54.8M |
| Q4 25 | $10.2M | $14.2M | ||
| Q3 25 | $9.1M | $12.8M | ||
| Q2 25 | $8.1M | $2.5M | ||
| Q1 25 | $7.1M | $21.5M | ||
| Q4 24 | $7.3M | $6.5M | ||
| Q3 24 | $7.6M | $2.8M | ||
| Q2 24 | $6.2M | $18.5M | ||
| Q1 24 | $6.0M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 48.1% | 32.5% | ||
| Q3 25 | 45.2% | 36.6% | ||
| Q2 25 | 43.7% | 33.6% | ||
| Q1 25 | 39.3% | 51.1% | ||
| Q4 24 | 39.5% | 10.6% | ||
| Q3 24 | 44.6% | 26.1% | ||
| Q2 24 | 38.8% | 51.4% | ||
| Q1 24 | 39.3% | 44.6% |
| Q4 25 | 39.4% | 35.9% | ||
| Q3 25 | 37.0% | 29.6% | ||
| Q2 25 | 35.8% | 5.7% | ||
| Q1 25 | 32.5% | 45.4% | ||
| Q4 24 | 33.1% | 14.7% | ||
| Q3 24 | 36.9% | 5.3% | ||
| Q2 24 | 32.1% | 34.8% | ||
| Q1 24 | 32.5% | 34.2% |
| Q4 25 | $0.91 | $0.15 | ||
| Q3 25 | $0.81 | $0.12 | ||
| Q2 25 | $0.72 | $0.02 | ||
| Q1 25 | $0.63 | $0.21 | ||
| Q4 24 | $0.66 | $0.05 | ||
| Q3 24 | $0.68 | $0.03 | ||
| Q2 24 | $0.55 | $0.20 | ||
| Q1 24 | $0.54 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $164.1M |
| Total DebtLower is stronger | $95.5M | $42.8M |
| Stockholders' EquityBook value | $283.1M | $248.3M |
| Total Assets | $3.2B | $380.4M |
| Debt / EquityLower = less leverage | 0.34× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | — | $152.7M | ||
| Q1 25 | — | $132.1M | ||
| Q4 24 | — | $125.0M | ||
| Q3 24 | — | $137.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $95.5M | $42.8M | ||
| Q3 25 | $95.5M | $21.1M | ||
| Q2 25 | $95.0M | $7.1M | ||
| Q1 25 | $70.0M | $6.9M | ||
| Q4 24 | $95.0M | $6.6M | ||
| Q3 24 | $95.0M | $823.2K | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | — |
| Q4 25 | $283.1M | $248.3M | ||
| Q3 25 | $274.6M | $248.0M | ||
| Q2 25 | $265.5M | $244.6M | ||
| Q1 25 | $259.7M | $226.4M | ||
| Q4 24 | $252.5M | $195.1M | ||
| Q3 24 | $256.8M | $205.0M | ||
| Q2 24 | $244.7M | $8.8M | ||
| Q1 24 | $242.6M | $9.0M |
| Q4 25 | $3.2B | $380.4M | ||
| Q3 25 | $3.2B | $321.4M | ||
| Q2 25 | $3.2B | $315.3M | ||
| Q1 25 | $3.2B | $284.6M | ||
| Q4 24 | $3.2B | $266.1M | ||
| Q3 24 | $3.1B | $296.5M | ||
| Q2 24 | $3.1B | $19.5M | ||
| Q1 24 | $3.0B | $19.8M |
| Q4 25 | 0.34× | 0.17× | ||
| Q3 25 | 0.35× | 0.09× | ||
| Q2 25 | 0.36× | 0.03× | ||
| Q1 25 | 0.27× | 0.03× | ||
| Q4 24 | 0.38× | 0.03× | ||
| Q3 24 | 0.37× | 0.00× | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.8M | $52.0M |
| Free Cash FlowOCF − Capex | $34.6M | $51.2M |
| FCF MarginFCF / Revenue | 133.9% | 129.3% |
| Capex IntensityCapex / Revenue | 12.5% | 2.0% |
| Cash ConversionOCF / Net Profit | 3.72× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.8M | $52.0M | ||
| Q3 25 | $12.9M | $-20.9M | ||
| Q2 25 | $7.4M | $-8.3M | ||
| Q1 25 | $2.2M | $1.9M | ||
| Q4 24 | $26.0M | $-7.3M | ||
| Q3 24 | $9.8M | $5.0M | ||
| Q2 24 | $6.4M | $19.2M | ||
| Q1 24 | $-1.5M | $3.7M |
| Q4 25 | $34.6M | $51.2M | ||
| Q3 25 | $12.6M | $-20.9M | ||
| Q2 25 | $7.2M | $-8.6M | ||
| Q1 25 | $828.0K | $1.7M | ||
| Q4 24 | $24.6M | $-7.9M | ||
| Q3 24 | $9.6M | $4.6M | ||
| Q2 24 | $6.3M | $18.3M | ||
| Q1 24 | $-1.8M | $3.0M |
| Q4 25 | 133.9% | 129.3% | ||
| Q3 25 | 51.4% | -48.3% | ||
| Q2 25 | 32.1% | -19.9% | ||
| Q1 25 | 3.8% | 3.5% | ||
| Q4 24 | 111.7% | -17.8% | ||
| Q3 24 | 47.0% | 8.7% | ||
| Q2 24 | 32.9% | 34.5% | ||
| Q1 24 | -9.8% | 5.4% |
| Q4 25 | 12.5% | 2.0% | ||
| Q3 25 | 1.2% | 0.1% | ||
| Q2 25 | 0.6% | 0.7% | ||
| Q1 25 | 6.2% | 0.5% | ||
| Q4 24 | 6.7% | 1.3% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.3% | 1.6% | ||
| Q1 24 | 1.8% | 1.3% |
| Q4 25 | 3.72× | 3.66× | ||
| Q3 25 | 1.42× | -1.63× | ||
| Q2 25 | 0.91× | -3.39× | ||
| Q1 25 | 0.31× | 0.09× | ||
| Q4 24 | 3.58× | -1.12× | ||
| Q3 24 | 1.29× | 1.77× | ||
| Q2 24 | 1.03× | 1.04× | ||
| Q1 24 | -0.25× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FNLC
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
